Implementing a Medicines at Transitions Intervention (MaTI) for patients with heart failure: a process evaluation of the Improving the Safety and Continuity Of Medicines management at Transitions of care (ISCOMAT) cluster randomised controlled trial

Catherine Powell, Hanif Ismail, Liz Breen, Beth Fylan, Sarah L Alderson, Chris P Gale, Peter Gardner, Jonathan Silcock, Bonnie Cundill, Amanda Farrin, Ellen Mason, Lauren Moreau, David P Alldred, Unknown, Gerry Armitage, Alison Blenkinsopp, Robert Turner, Andrew Taylor, Ian Kellar, Suzanne Hartley, Chris Bojke, John Wright

Open source

DOI
10.1186/s12913-024-11487-x
Published
2024-10-09
Container
BMC Health Services Research
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12913-024-11487-x,
  title = {Implementing a Medicines at Transitions Intervention (MaTI) for patients with heart failure: a process evaluation of the Improving the Safety and Continuity Of Medicines management at Transitions of care (ISCOMAT) cluster randomised controlled trial},
  author = {Catherine Powell and Hanif Ismail and Liz Breen and Beth Fylan and Sarah L Alderson and Chris P Gale and Peter Gardner and Jonathan Silcock and Bonnie Cundill and Amanda Farrin and Ellen Mason and Lauren Moreau and David P Alldred and Unknown and Gerry Armitage and Alison Blenkinsopp and Robert Turner and Andrew Taylor and Ian Kellar and Suzanne Hartley and Chris Bojke and John Wright},
  year = {2024},
  journal = {BMC Health Services Research},
  doi = {10.1186/s12913-024-11487-x},
  url = {https://doi.org/10.1186/s12913-024-11487-x}
}

RIS

TY  - JOUR
TI  - Implementing a Medicines at Transitions Intervention (MaTI) for patients with heart failure: a process evaluation of the Improving the Safety and Continuity Of Medicines management at Transitions of care (ISCOMAT) cluster randomised controlled trial
AU  - Catherine Powell
AU  - Hanif Ismail
AU  - Liz Breen
AU  - Beth Fylan
AU  - Sarah L Alderson
AU  - Chris P Gale
AU  - Peter Gardner
AU  - Jonathan Silcock
AU  - Bonnie Cundill
AU  - Amanda Farrin
AU  - Ellen Mason
AU  - Lauren Moreau
AU  - David P Alldred
AU  - Unknown
AU  - Gerry Armitage
AU  - Alison Blenkinsopp
AU  - Robert Turner
AU  - Andrew Taylor
AU  - Ian Kellar
AU  - Suzanne Hartley
AU  - Chris Bojke
AU  - John Wright
PY  - 2024
JO  - BMC Health Services Research
DO  - 10.1186/s12913-024-11487-x
UR  - https://doi.org/10.1186/s12913-024-11487-x
ER  - 

APA

Powell, C., Ismail, H., Breen, L., Fylan, B., Alderson, S. L., Gale, C. P., Gardner, P., Silcock, J., Cundill, B., Farrin, A., Mason, E., Moreau, L., Alldred, D. P., Unknown, Armitage, G., Blenkinsopp, A., Turner, R., Taylor, A., Kellar, I., Hartley, S., Bojke, C., & Wright, J. (2024). Implementing a Medicines at Transitions Intervention (MaTI) for patients with heart failure: a process evaluation of the Improving the Safety and Continuity Of Medicines management at Transitions of care (ISCOMAT) cluster randomised controlled trial. BMC Health Services Research. https://doi.org/10.1186/s12913-024-11487-x

Source records